Dudediligence.

Lifecore Biomedical, Inc

LFCRNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$37.9MMay ’24$24.7MAug ’24$32.6MNov ’24$35.2MFeb ’25$36.4MMay ’25$31.1MSep ’25$23.2MMar ’26$34.2MJun ’26
Net income, by quarter
−$7.1MMay ’24−$16.2MAug ’24−$6.6MNov ’24−$14.8MFeb ’25−$1.1MMay ’25−$10.0MSep ’25−$15.0MMar ’26−$6.2MJun ’26
Fiscal years, by the month each ended
LineMay 2021May 2022May 2023May 2024May 2025
Revenue$100.9M$111.3M$103.3M$128.3M$128.9M
Gross profit$38.9M$39.1M$28.0M$41.9M$40.3M
Operating income−$8.8M−$11.8M−$21.8M−$8.8M−$17.2M
Net income−$32.3M−$116.7M−$99.6M$12.0M−$38.7M
Operating cash flow$16.5M−$22.6M−$17.4M$257,000−$206,000
Free cash flow−$7.3M−$48.8Mnone on file−$18.1M−$13.6M
Cash$763,000$991,000$19.1M$8.5M$8.3M
Debt$164.9M$98.2M$84.8M$101.6Mnone on file
Shares outstanding29.3M29.5M30.3M30.6M37.0M